Llwytho...
The NRF2, Thioredoxin, and Glutathione System in Tumorigenesis and Anticancer Therapies
Cancer remains an elusive, highly complex disease and a global burden. Constant change by acquired mutations and metabolic reprogramming contribute to the high inter- and intratumor heterogeneity of malignant cells, their selective growth advantage, and their resistance to anticancer therapies. In t...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Antioxidants (Basel) |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
MDPI
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7699519/ https://ncbi.nlm.nih.gov/pubmed/33228209 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antiox9111151 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|